目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Alzheimer’s Therapeutics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Occurrence of Alzheimer’s Disease to Drive Market Growth
3.2.1.2 Large Number of Undiagnosed Patient’s and Revised Diagnostic Guidelines to Propel Growth
3.2.2 Market Restraining Factors
3.2.2.1 Shortage of Skilled Medical Professionals
3.2.2.2 Lack of Proper Treatment Techniques
3.2.3 Market Opportunities
3.2.3.1 Surge in Number of Mergers and Acquisitions to Boost Market Growth
3.2.3.2 Increasing R&D Investments and Collaborations
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PESTLE Analysis

4 Alzheimer’s Therapeutics Market Analysis by Drug
4.1 Key Findings
4.2 Drug Segment: Market Attractiveness Index
4.3 Alzheimer’s Therapeutics Market Share by Drug, 2022 & 2032
4.4 Donepezil
4.4.1 Donepezil Market Forecast by Region, 2022-2032 (US$ Mn)
4.4.2 Donepezil Market Share by Region, 2022 & 2032 (%)
4.5 Rivastigmine
4.5.1 Rivastigmine Market Forecast by Region, 2022-2032 (US$ Mn)
4.5.2 Rivastigmine Market Share by Region, 2022 & 2032 (%)
4.6 Memantine
4.6.1 Memantine Market Share by Region, 2022 & 2032 (%)
4.6.2 Memantine Market Share by Region, 2022 & 2032 (%)
4.7 Galantamine
4.7.1 Galantamine Market Forecast by Region, 2022-2032 (US$ Mn)
4.7.2 Galantamine Market Share by Region, 2022 & 2032 (%)
4.8 Manufactured Combination of Memantine and Donepezil
4.8.1 Manufactured Combination of Memantine and Donepezil Market Forecast by Region, 2022-2032 (US$ Mn)
4.8.2 Manufactured Combination of Memantine and Donepezil Market Share by Region, 2022 & 2032 (%)

5 Alzheimer’s Therapeutics Market Analysis by Drug Class
5.1 Key Findings
5.2 Drug Class Segment: Market Attractiveness Index
5.3 Alzheimer’s Therapeutics Market Share by Drug Class, 2022 & 2032
5.4 Cholinesterase Inhibitors
5.4.1 Cholinesterase Inhibitors Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Cholinesterase Inhibitors Market Share by Region, 2022 & 2032 (%)
5.5 NMDA Receptor Antagonists
5.5.1 NMDA Receptor Antagonists Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 NMDA Receptor Antagonists Market Share by Region, 2022 & 2032 (%)
5.6 Manufactured Combination
5.6.1 Manufactured Combination Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 Manufactured Combination Market Share by Region, 2022 & 2032 (%)

6 Alzheimer’s Therapeutics Market Analysis by Distribution Channel
6.1 Key Findings
6.2 Distribution Channel Segment: Market Attractiveness Index
6.3 Alzheimer’s Therapeutics Market Share by Distribution Channel, 2022 & 2032
6.4 Hospital Pharmacies
6.4.1 Hospital Pharmacies Market Forecast by Region, 2022-2032 (US$ Mn)
6.4.2 Hospital Pharmacies Market Share by Region, 2022 & 2032 (%)
6.5 Retail Pharmacies
6.5.1 Retail Pharmacies Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Retail Pharmacies Market Share by Region, 2022 & 2032 (%)
6.6 Drug Stores
6.6.1 Drug Stores Market Forecast by Region, 2022-2032 (US$ Mn)
6.6.2 Drug Stores Market Share by Region, 2022 & 2032 (%)
6.7 Online Pharmacies
6.7.1 Online Pharmacies Market Forecast by Region, 2022-2032 (US$ Mn)
6.7.2 Online Pharmacies by Region, 2022 & 2032 (%)

7 Alzheimer’s Therapeutics Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America Alzheimer’s Therapeutics Market Analysis
8.1 Key Findings
8.2 North America Alzheimer’s Therapeutics Market by Country, 2022, 2027 & 2032 (US$ mn)
8.3 North America Alzheimer’s Therapeutics Market Size Estimation and Forecast by Country
8.4 North America Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug
8.5 North America Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug Class
8.6 North America Alzheimer’s Therapeutics Market Size Estimation and Forecast by Distribution Channel
8.7 U.S. Alzheimer’s Therapeutics Market Analysis
8.8 Canada Alzheimer’s Therapeutics Market Analysis

9 Europe Alzheimer’s Therapeutics Market Analysis
9.1 Key Findings
9.2 Europe Alzheimer’s Therapeutics Market by Country, 2022, 2027 & 2032 (US$ mn)
9.3 Europe Alzheimer’s Therapeutics Market Size Estimation and Forecast by Country
9.4 Europe Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug
9.5 Europe Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug Class
9.6 Europe Alzheimer’s Therapeutics Market Size Estimation and Forecast by Distribution Channel
9.7 Germany Alzheimer’s Therapeutics Market Analysis
9.8 UK Alzheimer’s Therapeutics Market Analysis
9.9 France Alzheimer’s Therapeutics Market Analysis
9.10 Italy Alzheimer’s Therapeutics Market Analysis
9.11 Spain Alzheimer’s Therapeutics Market Analysis
9.12 Russia Alzheimer’s Therapeutics Market Analysis
9.13 Rest of Europe Alzheimer’s Therapeutics Market Analysis

10 Asia-Pacific Alzheimer’s Therapeutics Market Analysis
10.1 Key Findings
10.2 Asia-Pacific Alzheimer’s Therapeutics Market by Country, 2022, 2027 & 2032 (US$ mn)
10.3 Asia-Pacific Alzheimer’s Therapeutics Market Size Estimation and Forecast by Country
10.4 Asia-Pacific Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug
10.5 Asia-Pacific Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug Class
10.6 Asia-Pacific Alzheimer’s Therapeutics Market Size Estimation and Forecast by Distribution Channel
10.7 Japan Alzheimer’s Therapeutics Market Analysis
10.8 China Alzheimer’s Therapeutics Market Analysis
10.9 India Alzheimer’s Therapeutics Market Analysis
10.10 Australia Alzheimer’s Therapeutics Market Analysis
10.11 South Korea Alzheimer’s Therapeutics Market Analysis
10.12 Rest of Asia Pacific Alzheimer’s Therapeutics Market Analysis

11 Latin America Alzheimer’s Therapeutics Market Analysis
11.1 Key Findings
11.2 Latin America Alzheimer’s Therapeutics Market Size Estimation and Forecast by Country
11.3 Latin America Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug
11.4 Latin America Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug Class
11.5 Latin America Alzheimer’s Therapeutics Market Size Estimation and Forecast by Distribution Channel
11.6 Brazil Alzheimer’s Therapeutics Market Analysis
11.7 Mexico Alzheimer’s Therapeutics Market Analysis
11.8 Rest of Latin America Alzheimer’s Therapeutics Market Analysis

12 MEA Alzheimer’s Therapeutics Market Analysis
12.1 Key Findings
12.2 MEA Alzheimer’s Therapeutics Market by Country, 2022, 2027 & 2032 (US$ mn)
12.3 MEA Alzheimer’s Therapeutics Market Size Estimation and Forecast by Country
12.4 MEA Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug
12.5 MEA Alzheimer’s Therapeutics Market Size Estimation and Forecast by Drug Class
12.6 MEA Alzheimer’s Therapeutics Market Size Estimation and Forecast by Distribution Channel
12.7 GCC Alzheimer’s Therapeutics Market Analysis
12.8 South Africa Alzheimer’s Therapeutics Market Analysis
12.9 Rest of MEA Alzheimer’s Therapeutics Market Analysis

13 Company Profiles
13.1 Company Share Analysis
13.2 AbbVie, Inc.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2017-2021
13.2.3.2 Regional Market Shares, 2021
13.2.3.3 Business Segment Market Shares, 2021
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 Teva Pharmaceuticals Ltd., Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 Regional Market Shares, 2021
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Eisai Co., Ltd.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 Regional Market Shares, 2020
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2021
13.5.4 Product Benchmarking
13.6 Novartis AG
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2021
13.6.4 Product Benchmarking
13.6.5 Strategic Outlook
13.7 Zydus Lifesciences Ltd (CADILA)
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 Business Market Shares, 2021
13.7.4 Product Benchmarking
13.8 Sun Pharmaceutical Industries Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2017-2021
13.8.4 Product Benchmarking
13.9 Dr. Reddy's Laboratories Ltd
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 Regional Market Shares, 2021
13.9.3.3 Business Market Shares, 2021
13.9.4 Product Benchmarking
13.10 Aurobindo Pharma Ltd
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2021
13.10.3.2 Business Market Shares, 2021
13.10.4 Product Benchmarking
13.11 Amneal Pharmaceuticals Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2021
13.11.3.2 Business Market Shares, 2021
13.11.4 Product Benchmarking
13.11.5 Strategic Outlook
13.12 Macleods Pharmaceuticals Ltd.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2018-2020
13.12.3.2 Regional Market Shares, 2020
13.12.3.3 Business Market Shares, 2020
13.12.4 Product Benchmarking
13.13 Viatris Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.4 Product Benchmarking
13.14 Lupin Ltd
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 Regional Market Shares, 2021
13.14.3.3 Business Market Shares, 2021
13.14.4 Product Benchmarking
13.15 Cipla Ltd.
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2021
13.15.3.2 Business Market Shares, 2021
13.15.4 Product Benchmarking
13.15.5 Strategic Outlook
13.16 Torrent pharmaceuticals ltd.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2017-2021
13.16.4 Product Benchmarking

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

List of Tables
Table 1 Alzheimer’s Therapeutics Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Alzheimer’s Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%): V” Shaped Recovery Scenario
Table 3 Alzheimer’s Therapeutics Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Alzheimer’s Therapeutics Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Alzheimer’s Therapeutics Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Donepezil Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 7 Rivastigmine Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 8 Memantine Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 9 Galantamine Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 10 Manufactured Combination of Memantine and Donepezil Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 11 Cholinesterase Inhibitors Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 12 NMDA Receptor Antagonists Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 13 Manufactured Combination Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 14 Hospital Pharmacies Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 15 Retail Pharmacies Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 16 Drug Stores Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 17 Online Pharmacies Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 18 Alzheimer’s Therapeutics Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 19 North America Alzheimer’s Market Forecast by Country, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 20 North America Alzheimer’s Therapeutics Market Forecast by Drug, 2022-2032 (US$ million, AGR%, CAGR %)
Table 21 North America Alzheimer’s Therapeutics Market Forecast by Drug Class, 2022-2032 (US$ million, AGR%, CAGR%)
Table 22 North America Alzheimer’s Therapeutics Market Forecast by Distribution channel, 2022-2032 (US$ million, AGR%, CAGR%)
Table 23 U.S. Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 24 Canada Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 25 Europe Alzheimer’s Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 26 Europe Alzheimer’s Therapeutics Market Forecast by Drug, 2022-2032 (US$ million, AGR%, CAGR %)
Table 27 Europe Alzheimer’s Therapeutics Market Forecast by Drug Class, 2022-2032 (US$ million, AGR%, CAGR %)
Table 28 Europe Alzheimer’s Therapeutics Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR%)
Table 29 Germany Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 30 UK Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 31 France Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 32 Italy Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 33 Spain Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 34 Russia Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 35 Rest of Europe Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 36 Asia-Pacific Alzheimer’s Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 37 Asia-Pacific Alzheimer’s Therapeutics Market Forecast by Drug, 2022-2032 (US$ million, AGR%, CAGR %)
Table 38 Asia Pacific Alzheimer’s Therapeutics Market Forecast by Drug Class, 2022-2032 (US$ million, AGR%, CAGR %)
Table 39 Asia Pacific Alzheimer’s Therapeutics Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 40 Japan Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 41 China Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 42 India Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 43 Australia Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 44 South Korea Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 45 Rest of Asia Pacific Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR %)
Table 46 Latin America Alzheimer’s Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 47 Latin America Alzheimer’s Therapeutics Market Forecast by Drug, 2022-2032 (US$ million, AGR%, CAGR %)
Table 48 Latin America Alzheimer’s Therapeutics Market Forecast by Drug Class, 2022-2032 (US$ million, AGR %)
Table 49 Latin America Alzheimer’s Therapeutics Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 50 Brazil Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 51 Mexico Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 52 Rest of Latin America Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 53 MEA Alzheimer’s Therapeutics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 54 MEA Alzheimer’s Therapeutics Market Forecast by Drug, 2022-2032 (US$ million, AGR%, CAGR %)
Table 55 MEA Alzheimer’s Therapeutics Market Forecast by Drug Class, 2022-2032 (US$ million, AGR%, CAGR %)
Table 56 MEA Alzheimer’s Therapeutics Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 57 GCC Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 58 South Africa Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 59 Rest of MEA Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 60 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 61 AbbVie Inc.: Product Benchmarking
Table 62 AbbVie: Strategic Outlook
Table 63 Teva Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 64 Teva Pharmaceuticals Ltd.: Product Benchmarking
Table 65 Teva Pharmaceuticals Ltd.: Strategic Outlook
Table 66 Eisai Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 Eisai Co., Ltd.: Product Benchmarking
Table 68 Eisai Co., Ltd. Strategic Outlook
Table 69 Janssen Pharmaceuticals, Inc. (Johnson & Johnson): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Janssen Pharmaceuticals, Inc. (Johnson & Johnson): Product Benchmarking
Table 71 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Novartis AG: Product Benchmarking
Table 73 Novartis AG: Strategic Outlook
Table 74 Zydus Lifesciences Ltd (CADILA): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Zydus Lifesciences Ltd (CADILA): Product Benchmarking
Table 76 Sun Pharmaceutical Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Sun Pharmaceutical Industries Ltd.: Product Benchmarking
Table 78 Dr. Reddy's Laboratories Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Dr. Reddy's Laboratories Ltd: Product Benchmarking
Table 80 Aurobindo Pharma Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Aurobindo Pharma Ltd: Product Benchmarking
Table 82 Amneal Pharmaceuticals Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Amneal Pharmaceuticals Inc.: Product Benchmarking
Table 84 Amneal Pharmaceuticals Inc.: Strategic Outlook
Table 85 Macleods Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Macleods Pharmaceuticals Ltd.: Product Benchmarking
Table 87 Viatris Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Viatris Inc.: Product Benchmarking
Table 89 Lupin Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Lupin Ltd: Product Benchmarking
Table 91 Cipla Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Cipla Ltd.: Product Benchmarking
Table 93 Cipla Ltd.: Strategic Outlook
Table 94 Torrent pharmaceuticals ltd. Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Torrent pharmaceuticals ltd. Product Benchmarking

List of Figures
Figure 1 Alzheimer’s Therapeutics Market Segmentation
Figure 2 Alzheimer’s Therapeutics Market by Drug: Market Attractiveness Index
Figure 3 Alzheimer’s Therapeutics Market by Drug Class Segment: Market Attractiveness Index
Figure 4 Alzheimer’s Therapeutics Market by Distribution Channel: Market Attractiveness Index
Figure 5 Alzheimer’s Therapeutics Market: Market Dynamics
Figure 6 Global COVID Impact Analysis: Alzheimer’s Therapeutics Market Recovery Scenarios
Figure 7 Alzheimer’s Therapeutics Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Alzheimer’s Therapeutics Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Alzheimer’s Therapeutics Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Alzheimer’s Therapeutics Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Alzheimer’s Therapeutics Market: Porter’s Five Forces Analysis
Figure 12 Alzheimer’s Therapeutics Market: PESTLE Analysis
Figure 13 Alzheimer’s Therapeutics Market Forecast by Drug 2022, 2027, 2032 (Revenue, CAGR%)
Figure 14 Alzheimer’s Therapeutics Market Share Forecast by Therapeutics, 2022, 2032 (%)
Figure 15 Donepezil Market Forecast by Region, 2022-2032 (US$ million)
Figure 16 Donepezil Market Share Forecast by Region, 2022 & 2032 (%)
Figure 17 Rivastigmine Market Forecast by Region, 2022-2032 (US$ million)
Figure 18 Rivastigmine Market Share Forecast by Region, 2022 & 2032 (%)
Figure 19 Memantine Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Memantine Market Share Forecast by Region, 2022 & 2032 (%)
Figure 21 Galantamine Market Forecast by Region, 2022-2032 (US$ million)
Figure 22 Galantamine Market Share Forecast by Region, 2022 & 2032 (%)
Figure 23 Manufactured Combination of Memantine and Donepezil Market Forecast by Region, 2022-2032 (US$ million)
Figure 24 Manufactured Combination of Memantine and Donepezil Market Share Forecast by Region, 2022 & 2032 (%)
Figure 25 Alzheimer’s Therapeutics Market Forecast by Drug Class 2022, 2027, 2032 (Revenue, CAGR%)
Figure 26 Alzheimer’s Therapeutics Market Share Forecast by Drug Class, 2022, 2032 (%)
Figure 27 Cholinesterase Inhibitors Market Forecast by Region, 2022-2032 (US$ million)
Cholinesterase Inhibitors Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 NMDA Receptor Antagonists Market Forecast by Region, 2022-2032 (US$ million)
Figure 29 NMDA Receptor Antagonists Market Share Forecast by Region, 2022 & 2032 (%)
Figure 30 Manufactured Combination Market Forecast by Region, 2022-2032 (US$ million)
Figure 31 Manufactured Combination Market Share Forecast by Region, 2022 & 2032 (%)
Figure 32 Alzheimer’s Therapeutics Market Forecast by Distribution Channel 2022, 2027, 2032 (Revenue, CAGR%)
Figure 33 Alzheimer’s Therapeutics Market Share Forecast by Therapeutics, 2022, 2032 (%)
Figure 34 Hospital Pharmacies Market Forecast by Region, 2022-2032 (US$ million)
Figure 35 Hospital Pharmacies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 36 Retail Pharmacies Market Forecast by Region, 2022-2032 (US$ million)
Figure 37 Retail Pharmacies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 38 Drug Stores Market Forecast by Region, 2022-2032 (US$ million)
Figure 39 Drug Stores Market Share Forecast by Region, 2022 & 2032 (%)
Figure 40 Online Pharmacies Market Forecast by Region, 2022-2032 (US$ million)
Figure 41 Online Pharmacies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 53 U.S. Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 54 Canada Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 64 Germany Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 65 UK Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 66 France Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 67 Italy Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 68 Spain Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 69 Russia Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 70 Rest of Europe Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 80 Japan Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 81 China Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 82 India Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 83 Australia Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 84 South Korea Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 85 Rest of Asia Pacific Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 94 Brazil Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 95 Mexico Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 96 Rest of Latin America Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 105 GCC Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 106 South Africa Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 107 Rest of MEA Alzheimer’s Therapeutics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 108 Alzheimer’s Therapeutics Market: Company Share Analysis, 2021
Figure 109 AbbVie Inc.: Net Revenue, 2017-2021 (US$ billion)
Figure 110 AbbVie Inc.: Regional Market Shares, 2021
Figure 111 AbbVie Inc.: Business Market Shares, 2021
Figure 112 Teva Pharmaceuticals Ltd.: Net Revenue, 2017-2021 (US$ million)
Figure 113 Teva Pharmaceuticals Ltd.: Regional Market Shares, 2021
Figure 114 Eisai Co., Ltd.: Net Revenue, 2017-2021 (US$ million)
Figure 115 Eisai Co., Ltd.: Regional Market Shares, 2021
Figure 116 Janssen Pharmaceuticals, Inc. (Johnson & Johnson): Net Revenue, 2017-2021 (US$ million)
Figure 117 Novartis AG: Net Revenue, 2017-2021 (US$ million)
Figure 118 Zydus Lifesciences Ltd (CADILA): Net Revenue, 2017-2021 (US$ million)
Figure 119 Zydus Lifesciences Ltd (CADILA): Business Market Shares, 2021
Figure 120 Sun Pharmaceutical Industries Ltd.: Net Revenue, 2017-2021 (US$ Million)
Figure 121 Dr. Reddy's Laboratories Ltd: Net Revenue, 2017-2021 (US$ Million)
Figure 122 Dr. Reddy's Laboratories Ltd: Regional Market Shares, 2021
Figure 123 Dr. Reddy's Laboratories Ltd.: Business Market Shares, 2021
Figure 124 Aurobindo Pharma Ltd: Net Revenue, 2017-2021 (US$ million)
Figure 125 Aurobindo Pharma Ltd: Business Market Shares, 2021
Figure 126 Amneal Pharmaceuticals Inc.: Net Revenue, 2017-2021 (US$ ‘000’)
Figure 127 Amneal Pharmaceuticals Inc.: Business Market Shares, 2021
Figure 128 Macleods Pharmaceuticals Ltd.: Net Revenue, 2018-2020 (US$ million)
Figure 129 Macleods Pharmaceuticals Ltd.: Regional Market Shares, 2020
Figure 130 Macleods Pharmaceuticals Ltd.: Business Market Shares, 2020
Figure 131 Viatris Inc.: Net Revenue, 2017-2021 (US$ million)
Figure 132 Lupin Ltd: Net Revenue, 2017-2021 (US$ billion)
Figure 133 Lupin Ltd: Regional Market Shares, 2021
Figure 134 Lupin Ltd: Business Market Shares, 2021
Figure 135 Cipla Ltd.: Net Revenue, 2017-2021 (US$ million)
Figure 136 Cipla Ltd.: Business Market Shares, 2021
Figure 137 Torrent pharmaceuticals ltd.: Net Revenue, 2017-2021 (US$ million)